Fig. 6From: Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritisAdverse events of free drug and siRML and F-siRML were evaluated in terms of lymphocyte count. The blood was collected after every administration of the formulations. The blood was collected 5 h after the administration of the formulationsBack to article page